AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Market experts have recommended more several stocks to BUY tomorrow (February 3). The top recommendations are Zydus Life, ...

Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences Limited and Takeda ...

In the first randomized trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not ...

Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday thanked the Government for bestowing Padma Bhushan upon him, and said he was “extremely grateful for the recognition”. Pankaj Ramanbhai Patel, ...

The Ahmedabad -based Patel, whose Zydus Group runs a chain of multi-specialty hospitals, further said, “We are taking a leap ...

Innovation from India will bring critical access to affordable healthcare and empower people to lead healthier and more fulfilled lives, said Zydus Lifesciences Chairman Pankaj R Patel who has been ...

Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday expressed his gratitude upon being bestowed with the Padma Bhushan ...

Architect of Ayodhya Ram Mandir, Chandrakant Sompura's father and architect of the Somnath Temple, Prabhashankar Sompura, had ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...